InsidersTradesSigma
20/20 Biolabs, Inc. Stock: price and insider trades · United States · SEC (Form 4)
SEC:2020-biolabs-inc-35b8fbUS·SEC (Form 4)
Track the 20/20 Biolabs, Inc. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares trade on US US, under the authority of SEC (Form 4). The latest transaction was disclosed on 23 February 2026 (C). Among the most active insiders: Rollins John Woodson. Every trade is accessible without an account.
4
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
11Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 23 February 2026
Declarations4 total
13,029 shares0Common StockSEC:0001213900-26-019456:0
31 shares0Common StockSEC:0001213900-26-019424:0
7,669 shares0Common StockSEC:0001213900-26-019423:0
7,700 shares0Common StockSEC:0001213900-26-019421:0
4 of 4 declarations
About 20/20 Biolabs, Inc.
20/20 Biolabs, Inc. is a biotechnology company focused on developing innovative solutions for research and medical applications. It is listed on the XNAS market.